关注
Tal Yardeni
Tal Yardeni
在 sheba.health.gov.il 的电子邮件经过验证
标题
引用次数
引用次数
年份
Retro-orbital injections in mice
T Yardeni, M Eckhaus, HD Morris, M Huizing, S Hoogstraten-Miller
Lab animal 40 (5), 155-160, 2011
5142011
Host mitochondria influence gut microbiome diversity: A role for ROS
T Yardeni, CE Tanes, K Bittinger, LM Mattei, PM Schaefer, LN Singh, ...
Science signaling 12 (588), eaaw3159, 2019
1332019
UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE): a master regulator of sialic acid synthesis
R Gerardy-Schahn, P Delannoy, M von Itzstein, S Hinderlich, ...
SialoGlyco Chemistry and Biology I: Biosynthesis, structural diversity and …, 2015
1102015
Genotype–phenotype correlations analysis of mutations in the phenylalanine hydroxylase (PAH) gene
D Bercovich, A Elimelech, J Zlotogora, S Korem, T Yardeni, N Gal, ...
Journal of human genetics 53 (5), 407-418, 2008
732008
A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C‐methyltransferase deficiency
MCV Malicdan, T Vilboux, B Ben‐Zeev, J Guo, A Eliyahu, ...
Human mutation 39 (1), 69-79, 2018
592018
Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy
O Barel, MCV Malicdan, B Ben-Zeev, J Kandel, H Pri-Chen, J Stephen, ...
Brain 140 (3), 568-581, 2017
502017
Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy
TK Niethamer, T Yardeni, P Leoyklang, C Ciccone, A Astiz-Martinez, ...
Molecular genetics and metabolism 107 (4), 748-755, 2012
502012
Hereditary Inclusion Body Myopathy: Single Patient Response to Intravenous Dosing of GNE Gene Lipoplex
G Nemunaitis, CM Jay, PB Maples, WA Gahl, M Huizing, T Yardeni, ...
Human gene therapy 22 (11), 1331-1341, 2011
492011
The Gne M712T mouse as a model for human glomerulopathy
S Kakani, T Yardeni, J Poling, C Ciccone, T Niethamer, ED Klootwijk, ...
The American journal of pathology 180 (4), 1431-1440, 2012
372012
A Mutation Analysis of the Phenylalanine Hydroxylase (PAH) Gene in the Israeli Population
D Bercovich, A Elimelech, T Yardeni, S Korem, J Zlotogora, N Gal, ...
Annals of human genetics 72 (3), 305-309, 2008
372008
Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria
N Kurochkina, T Yardeni, M Huizing
Glycobiology 20 (3), 322-337, 2010
362010
An mtDNA mutant mouse demonstrates that mitochondrial deficiency can result in autism endophenotypes
T Yardeni, AG Cristancho, AJ McCoy, PM Schaefer, MJ McManus, ...
Proceedings of the National Academy of Sciences 118 (6), e2021429118, 2021
342021
Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase
T Yardeni, T Choekyi, K Jacobs, C Ciccone, K Patzel, Y Anikster, WA Gahl, ...
Biochemistry 50 (41), 8914-8925, 2011
302011
High content image analysis reveals function of miR-124 upstream of Vimentin in regulating motor neuron mitochondria
T Yardeni, R Fine, Y Joshi, T Gradus-Pery, N Kozer, I Reichenstein, ...
Scientific reports 8 (1), 59, 2018
262018
Sialylation of Thomsen–Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy
P Leoyklang, MC Malicdan, T Yardeni, F Celeste, C Ciccone, X Li, ...
Biomarkers in medicine 8 (5), 641-652, 2014
212014
Non-specific accumulation of glycosphingolipids in GNE myopathy
KA Patzel, T Yardeni, E Le Poëc-Celic, P Leoyklang, H Dorward, ...
Journal of inherited metabolic disease 37, 297-308, 2014
142014
Combination of common mtDNA variants results in mitochondrial dysfunction and a connective tissue dysregulation
PM Schaefer, L Scherer Alves, M Lvova, J Huang, K Rathi, K Janssen, ...
Proceedings of the National Academy of Sciences 119 (45), e2212417119, 2022
112022
Rationale and design for a phase 1 study of N-acetylmannosamine for primary glomerular diseases
M Huizing, T Yardeni, F Fuentes, MCV Malicdan, P Leoyklang, A Volkov, ...
Kidney International Reports 4 (10), 1454-1462, 2019
112019
DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients
R Shapiro, Y Anikster, T Yardeni, S Korem, K Hartman, R Shamir, ...
Journal of human genetics 55 (5), 308-313, 2010
102010
Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice
PM Schaefer, J Huang, A Butic, C Perry, T Yardeni, W Tan, R Morrow, ...
Molecular Metabolism 64, 101560, 2022
82022
系统目前无法执行此操作,请稍后再试。
文章 1–20